News and Announcements
Full House at the Sydney Fund Manager Investor Evening
- Published June 22, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Events
Last night, Wholesale Investor hosted the Sydney Fund Manager Investor Evening in the spectacular new offices at PwC, Barangaroo. With over 170 attendees the event was at full capacity turning into a standing room only.
The event featured 7 exclusive funds, including a special presentation from our guest speaker, Ben Dodwell from Folkestone Ltd (ASX: FLK) who spoke of his role at Folkestone, past experiences and his observation in the market. Other presenting funds include:
- Qove Capital Golf Heights Gosford Ltd– Residential development project in Gosford City, with fixed return of up to 30% over the life of the project; Already $1.5m raised; OFFER CLOSING TOMORROW (23rd June)
- CVC Add+Venture Fund– Venture capital fund launched by an ASX listed investment management company with net assets of over $200m
- Quantum Group– Leading property investment company providing a range of financial services
- Newground Capital– Real estate investment manager investing in compelling opportunistic and value-add real estate
- Trilogy Funds– Mortgage and property trust offering with competitive yields and consistent distributions
- Peer Estate– Peer-to-peer platform for real estate debt with strong risk return fundamentals
Our Melbourne Fund Manager Investor Evening takes place next week (28th June) at RACV, where the fund managers will provide investors with a final opportunity to see them present live at a Wholesale Investor event.
We would like to thank all of the investors who joined us at this event and a very brave QLD supporter, along with the fund managers which presented.
If you are interested in attending our other upcoming events in Melbourne, Singapore and Sydney, including our Small Cap Showcases in July please click on the button below.
Events
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
